BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21261663)

  • 1. Functional effects of interleukin 31 in human primary keratinocytes.
    Kasraie S; Niebuhr M; Baumert K; Werfel T
    Allergy; 2011 Jul; 66(7):845-52. PubMed ID: 21261663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients.
    Niebuhr M; Heratizadeh A; Wichmann K; Satzger I; Werfel T
    Exp Dermatol; 2011 Jun; 20(6):468-72. PubMed ID: 21447101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-31: a new link between T cells and pruritus in atopic skin inflammation.
    Sonkoly E; Muller A; Lauerma AI; Pivarcsi A; Soto H; Kemeny L; Alenius H; Dieu-Nosjean MC; Meller S; Rieker J; Steinhoff M; Hoffmann TK; Ruzicka T; Zlotnik A; Homey B
    J Allergy Clin Immunol; 2006 Feb; 117(2):411-7. PubMed ID: 16461142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins.
    Kasraie S; Niebuhr M; Werfel T
    Allergy; 2010 Jun; 65(6):712-21. PubMed ID: 19889120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis.
    Niebuhr M; Lutat C; Sigel S; Werfel T
    Allergy; 2009 Nov; 64(11):1580-7. PubMed ID: 19392987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis.
    Nobbe S; Dziunycz P; Mühleisen B; Bilsborough J; Dillon SR; French LE; Hofbauer GF
    Acta Derm Venereol; 2012 Jan; 92(1):24-8. PubMed ID: 22041865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.
    Bilsborough J; Leung DY; Maurer M; Howell M; Boguniewicz M; Yao L; Storey H; LeCiel C; Harder B; Gross JA
    J Allergy Clin Immunol; 2006 Feb; 117(2):418-25. PubMed ID: 16461143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a regulatory loop between IFN-γ and IL-33 in skin inflammation.
    Seltmann J; Werfel T; Wittmann M
    Exp Dermatol; 2013 Feb; 22(2):102-7. PubMed ID: 23362867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced CCL26 production by IL-4 through IFN-gamma-induced upregulation of type 1 IL-4 receptor in keratinocytes.
    Nishi N; Yamamoto S; Ou W; Muro E; Inada Y; Hamasaki Y
    Biochem Biophys Res Commun; 2008 Nov; 376(1):234-40. PubMed ID: 18774776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR-2-mediated cytokine and chemokine secretion in human keratinocytes.
    Niebuhr M; Baumert K; Werfel T
    Exp Dermatol; 2010 Oct; 19(10):873-7. PubMed ID: 20849532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
    Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
    J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis.
    Mrabet-Dahbi S; Dalpke AH; Niebuhr M; Frey M; Draing C; Brand S; Heeg K; Werfel T; Renz H
    J Allergy Clin Immunol; 2008 Apr; 121(4):1013-9. PubMed ID: 18234309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis.
    Meyer N; Zimmermann M; Bürgler S; Bassin C; Woehrl S; Moritz K; Rhyner C; Indermitte P; Schmid-Grendelmeier P; Akdis M; Menz G; Akdis CA
    J Allergy Clin Immunol; 2010 Apr; 125(4):858-865.e10. PubMed ID: 20227751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis.
    Cheung PF; Wong CK; Ho AW; Hu S; Chen DP; Lam CW
    Int Immunol; 2010 Jun; 22(6):453-67. PubMed ID: 20410259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis.
    Pastore S; Corinti S; La Placa M; Didona B; Girolomoni G
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):538-44. PubMed ID: 9564808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
    Albanesi C; Cavani A; Girolomoni G
    J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22.
    Honma M; Minami-Hori M; Takahashi H; Iizuka H
    J Dermatol Sci; 2012 Feb; 65(2):134-40. PubMed ID: 22189341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in interleukin-21 in children suffering with severe atopic dermatitis.
    Lin SC; Chuang YH; Yang YH; Chiang BL
    Pediatr Allergy Immunol; 2011 Dec; 22(8):869-75. PubMed ID: 22122790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response.
    Eyerich K; Pennino D; Scarponi C; Foerster S; Nasorri F; Behrendt H; Ring J; Traidl-Hoffmann C; Albanesi C; Cavani A
    J Allergy Clin Immunol; 2009 Jan; 123(1):59-66.e4. PubMed ID: 19056110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis.
    Rebane A; Zimmermann M; Aab A; Baurecht H; Koreck A; Karelson M; Abram K; Metsalu T; Pihlap M; Meyer N; Fölster-Holst R; Nagy N; Kemeny L; Kingo K; Vilo J; Illig T; Akdis M; Franke A; Novak N; Weidinger S; Akdis CA
    J Allergy Clin Immunol; 2012 May; 129(5):1297-306. PubMed ID: 22445417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.